Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
ACS Omega|February 16, 2026
Novel, Achiral 4‑Nitroimidazole Compounds with Potent Antitubercular ActivityTshwanelo B Matlala, Phelelisiwe S Dube, Audrey Jordaan, et al.
Chemical Biology & Drug Design|June 20, 2020
Synthesis and evaluation of C3 substituted chalcone-based derivatives of 7-azaindole as protein kinase inhibitorsMalikotsi A Qhobosheane, Lesetja J Legoabe, Béatrice Josselin, et al.
Frontiers in Pharmacology|September 12, 2022
The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malariaDaniel J Watson, Lizahn Laing, Richard M Beteck, et al.
Chemical Biology & Drug Design|November 9, 2022
Arylnitro monocarbonyl curcumin analogues: Synthesis and in vitro antitubercular evaluationCharné du Preez, Lesetja J Legoabe, Audrey Jordaan, et al.
Medicina (Kaunas, Lithuania)|May 30, 2019
Anti-Trypanosomal and Antimalarial Properties of Tetralone Derivatives and Structurally Related BenzocycloalkanonesRichard M Beteck, Lesetja J Legoabe, Michelle Isaacs, et al.
European Journal of Medicinal Chemistry|June 15, 2023
Quinolone analogues of benzothiazinone: Synthesis, antitubercular structure-activity relationship and ADME profilingPhelelisiwe S Dube, Lesetja J Legoabe, Audrey Jordaan, et al.
Archiv Der Pharmazie|March 12, 2021
Synthesis of 2-(N-cyclicamino)quinoline combined with methyl (E)-3-(2/3/4-aminophenyl)acrylates as potential antiparasitic agentsFostino R B Bokosi, Richard M Beteck, Dustin Laming, et al.
Chemico-Biological Interactions|April 27, 2021
Exploration of 7-azaindole-coumaranone hybrids and their analogues as protein kinase inhibitorsMalikotsi A Qhobosheane, Richard M Beteck, Blandine Baratte, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2016
Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activitiesRichard M Beteck, Dina Coertzen, Frans J Smit, et al.
Molecules (Basel, Switzerland)|May 8, 2019
New Quinolone-Based Thiosemicarbazones Showing Activity Against <i>Plasmodium falciparum</i> and <i>Mycobacterium tuberculosis</i>Richard M Beteck, Ronnett Seldon, Audrey Jordaan, et al.
Pageof 5